Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy Academic Article uri icon

Overview

MeSH Major

  • Adjuvants, Immunologic
  • BCG Vaccine
  • Cystectomy
  • Urinary Bladder Neoplasms

abstract

  • Restaging TUR of high risk superficial bladder cancer improves the initial response rate to BCG therapy, reduces the frequency of subsequent tumor recurrence and appears to delay early tumor progression.

publication date

  • December 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.ju.0000181799.81119.fc

PubMed ID

  • 16280743

Additional Document Info

start page

  • 2134

end page

  • 7

volume

  • 174

number

  • 6